Calidinol Tablets (Calidinogenase)

Adult dose

Administer 30-150 I.U. orally in 3 divided doses daily. Dosage may be adjusted as appropriate according to age and symptoms.

This medication should not be used in patients with bleeding conditions such as cerebral hemorrhage. Additionally, since this medication contains lactose, it should not be administered to patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Caution should be taken for allergic reactions when using this medication. Skin rashes or itching may occasionally occur, and if these symptoms appear, the medication should be discontinued. Rarely, symptoms of rapid heartbeat may occur, so if there are any cardiac-related symptoms, it is important to consult with medical personnel. Gastrointestinal symptoms such as discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur, and if these symptoms persist, it should be reported. Additionally, symptoms such as fever, headache, dizziness, drowsiness, and fatigue may also appear rarely, so caution is advised. For elderly patients, special care should be taken when using this medication, including possible dose reduction due to diminished physical function.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best to keep it at room temperature away from direct sunlight. This will help maintain the medication's effectiveness for a longer period.

Appearance

White round enteric-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle